Acadia Healthcare (NASDAQ:ACHC) Stock Rating Upgraded by Deutsche Bank Aktiengesellschaft

Acadia Healthcare (NASDAQ:ACHC) was upgraded by equities research analysts at Deutsche Bank Aktiengesellschaft from a “sell” rating to a “hold” rating in a report released on Thursday, Marketbeat.com reports. The firm currently has a $70.00 price objective on the stock. Deutsche Bank Aktiengesellschaft’s price objective would indicate a potential downside of 4.88% from the company’s current price.

Other equities research analysts have also issued reports about the company. Stephens raised Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target for the company in a research note on Friday, January 5th. UBS Group lifted their price target on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Mizuho lifted their price target on Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 6th. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. Finally, TheStreet raised Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, Acadia Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $92.00.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $73.59 on Thursday. The company has a market cap of $6.80 billion, a PE ratio of -294.35, a price-to-earnings-growth ratio of 2.10 and a beta of 1.31. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The stock has a 50-day moving average price of $78.07 and a 200-day moving average price of $77.66. Acadia Healthcare has a 12-month low of $66.49 and a 12-month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The company had revenue of $742.80 million for the quarter, compared to analysts’ expectations of $727.60 million. During the same period in the prior year, the firm earned $0.70 earnings per share. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. As a group, equities analysts forecast that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Insider Activity at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the sale, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.80% of the stock is owned by insiders.

Institutional Trading of Acadia Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the company. New York State Teachers Retirement System grew its stake in shares of Acadia Healthcare by 0.3% during the 1st quarter. New York State Teachers Retirement System now owns 76,054 shares of the company’s stock valued at $6,025,000 after buying an additional 200 shares during the period. Louisiana State Employees Retirement System grew its stake in shares of Acadia Healthcare by 2.3% during the 1st quarter. Louisiana State Employees Retirement System now owns 26,500 shares of the company’s stock valued at $2,099,000 after buying an additional 600 shares during the period. Raymond James Financial Services Advisors Inc. increased its holdings in Acadia Healthcare by 24.9% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 55,322 shares of the company’s stock valued at $4,383,000 after purchasing an additional 11,022 shares in the last quarter. Raymond James & Associates increased its holdings in Acadia Healthcare by 20.0% in the 1st quarter. Raymond James & Associates now owns 117,560 shares of the company’s stock valued at $9,313,000 after purchasing an additional 19,618 shares in the last quarter. Finally, DB Fitzpatrick & Co Inc increased its holdings in Acadia Healthcare by 93.7% in the 1st quarter. DB Fitzpatrick & Co Inc now owns 13,763 shares of the company’s stock valued at $1,090,000 after purchasing an additional 6,659 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.